UPDATED Research & Experimental Tax Deduction Guidance by Mark B. Leaheey, CPA, CGMA, MSA
Posted on September 17, 2024 by Mark Leaheey
On Aug. 1, 2024, the U.S. Senate failed to pass a tax bill that, among other things, would have restored businesses’ ability to fully deduct specified research and experimental (SRE) expenses in the tax year they are incurred. As a result, businesses that invest in innovation must continue to capitalize and amortize those costs over […]